cigna8k.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (Date of earliest event reported) March 4,
2008
CIGNA
Corporation
(Exact
name of registrant as specified in its charter)
|
Delaware
(State
or other jurisdiction of incorporation)
|
1-08323
(Commission
File Number)
|
06-1059331
(IRS
Employer
Identification
No.)
|
Two
Liberty Place, 1601 Chestnut Street
Philadelphia, Pennsylvania
19192
(Address
of principal executive offices) (Zip Code)
Registrant's
telephone number, including area code:
(215)
761-1000
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[
] Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Item
8.01 Other Events
On March
4, 2008, CIGNA Corporation (the "Company") entered into an Underwriting
Agreement (the "Underwriting Agreement"), by and among the Company
and Banc of America Securities LLC and Goldman, Sachs & Co., as
representatives of the underwriters named in Schedule I thereto, with respect to
the issuance and sale by the Company of $300,000,000 aggregate principal amount
of 6.35% Senior Notes due 2018 (the "Notes"). The Notes are being sold pursuant
to an effective shelf registration statement on Form S-3, File No. 333-136704).
A copy of the Underwriting Agreement is filed as Exhibit 1.1
hereto.
The terms
of the Notes are governed by a Senior Indenture, dated as of August 16,
2006, between the Company and U.S. Bank National Association, as trustee,
as supplemented by Supplemental Indenture No. 3, dated as of March 7,
2008 (the “Supplemental Indenture”). The Supplemental Indenture with
respect to the Notes (including the form of the Note) is filed as Exhibit
4.1 hereto.
Item
9.01 Financial Statements and
Exhibits
(d)
Exhibits.
4.2 Form
of Note (included as Annex A to Exhibit 4.1)
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Date:
March 10, 2008
|
By:
|
/s/
Nicole S. Jones |
|
|
Name:
|
Nicole
S. Jones
|
|
|
Title:
|
Corporate
Secretary and
|
|
|
|
Vice
President, Corporate and Financial
Law
|